
Insights from a genome-wide association study identify novel genetic loci

Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors

The therapy planning support tool has been trained on thousands of patient cases from more than 200 retina centres throughout Europe

The Optegra platform currently operates in the Czech Republic, the Netherlands, Poland, Slovakia and the United Kingdom

Lysine, proline and arginine levels progressively increased from non-proliferative DR to proliferative DR stages

New clinical guidance for anterior and posterior uveitis was published by a research team from the University of Bristol

At the Retina World Congress, we spoke with Siegfried Priglinger, MD, about ensuring the best outcomes for preschool-aged patients

Vitamins B6, B9 and B12 were found to be neuroprotective against retinal ganglion cell death

At the 2025 ASCRS meeting, Dr Ang said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery

Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia

The OCT platform offers deep imaging depth, rapid sweeping speed, extensive scan range, accurate results and multimodal imaging capabilities

Detecting mitochondrial dysfunction may give clinicians a chance to reduce the rate of cognitive decline in patients with dementia

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

Three dose level cohorts of the small interfering RNA therapeutic were evaluated in a double-blind study

Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States

The company shared results from the AAVB-081 clinical programme and AAVB-039 preclinical programme at ARVO

The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia

The biomarkers are especially crucial for patients with lupus nephritis

Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles.

The LuxLife full range of vision intraocular lens is available in a range of cylinders spanning from +0.75D to +6.00D.

Teprotumumab is the first therapy specifically licensed for the treatment of moderate-to-severe thyroid eye disease in the UK

At the 2025 ARVO annual meeting, Prof Sadun shared an exciting update in our understanding of Leber hereditary optic neuropathy

Utilizing artificial intelligence (AI), Cascader is a new medical technology company that aims to transform the detection and management of eye disease.



Opus Genetics reveals promising 1-year results from OPGx-LCA5 gene therapy, showing sustained vision improvements in adults with LCA5 retinal degeneration.

Research findings compare the rotational stability of a monofocal plus toric IOL with traditional toric lenses

Prof Loewenstein and a cohort of colleagues assessed the current treatment outlook for patients with diabetic retinopathy

Members of the Ophthalmology Times Europe, Ophthalmology Times and Modern Retina editorial advisory boards are present and presenting at the 2025 ARVO meeting

Carl Zeiss Meditec plans to launch the ZEISS RDP in select countries throughout 2025